BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+31.6%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$1.84B
AUM Growth
+$1.84B
(+32%)
Cap. Flow
+$76.3M
Cap. Flow
% of AUM
4.15%
Top 10 Holdings %
Top 10 Hldgs %
79.12%
Holding
28
New
5
Increased
6
Reduced
9
Closed
4
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$55.2M |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$41.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$31.9M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$23.2M |
| 5 |
Neurocrine Biosciences
NBIX
|
$22.1M |
Top Sells
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$25.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$23.3M |
| 3 |
Incyte
INCY
|
$22.7M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$21.3M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 86.17% |